Be Prepared to Treat Multidrug-Resistant "ESBL" and "CRE" Infections
April 2017
You'll hear more about treating "superbugs" such as ESBL and CRE...due to a push from the World Health Organization.
Extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae are popping up everywhere. And most states are reporting carbapenem-resistant Enterobacteriaceae (CRE)...which is fatal in about 50% of cases.
Help prevent progression of superbugs with judicious antibiotic use.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote